Web Analytics

Investor Profile

Sofinnova Investments

Sofinnova Investments United States - Menlo Park, CA
INVESTOR

1 Disclosed Funding Rounds $53,000,000
7 Participating Investments




Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a clinical-stage biopharmaceutical

Invested In

Company Date Round Raised
  Antiva Biosciences, Inc. April, 27 ,2023 Series E $53,000,000
  Quanta Therapeutics May, 23 ,2023 Series D $50,000,000
  Star Therapeutics September, 05 ,2023 Series C $90,000,000
  Aiolos Bio October, 26 ,2023 Series A $245,000,000
  Capstan Therapeutics March, 21 ,2024 Series B $175,000,000
  Marea Therapeutics June, 20 ,2024 Series A $190,000,000
  Axonis Therapeutics October, 31 ,2024 Series A $115,000,000